Z Y Li1, S Q Zou. 1. Department of General Surgery of Tongji Hospital, Wuhan 430030, Hubei Province, China.
Abstract
AIM: To investigate FasL expression in hilar cholangiocarcinoma tissues and cultured cholangiocarcinoma cells, and to assess its ability to induce apoptosis. METHODS: We studied the expression of FasL by human hilar cholangiocaroinomas tissues by immunohistochemistry, and the QBC939 cholangiocarcinoma cell line by RT-PCR, immunohistochemistry, and Western Blot. TUNEL and flow cytometry were used to detect apoptotic cells. RESULTS: Prevalent expression of FasL was detected in 39 resected hilar cholangiocarcinoma tissues. TUNEL staining disclosed a high level of cell death among lymphocytes infiltrating FasL positive areas of tumor. FasL mRNA and protein expressions in cholangiocarcinoma cells could induce Jurkat cells. CONCLUSION: Hilar cholangiocarcinomas may elude immunological surveillance by inducing, via Fas/FasL system, the apoptosis of activated lymphocytes.
AIM: To investigate FasL expression in hilar cholangiocarcinoma tissues and cultured cholangiocarcinoma cells, and to assess its ability to induce apoptosis. METHODS: We studied the expression of FasL by human hilar cholangiocaroinomas tissues by immunohistochemistry, and the QBC939 cholangiocarcinoma cell line by RT-PCR, immunohistochemistry, and Western Blot. TUNEL and flow cytometry were used to detect apoptotic cells. RESULTS: Prevalent expression of FasL was detected in 39 resected hilar cholangiocarcinoma tissues. TUNEL staining disclosed a high level of cell death among lymphocytes infiltrating FasL positive areas of tumor. FasL mRNA and protein expressions in cholangiocarcinoma cells could induce Jurkat cells. CONCLUSION: Hilar cholangiocarcinomas may elude immunological surveillance by inducing, via Fas/FasL system, the apoptosis of activated lymphocytes.
Authors: G Bellone; C Smirne; A Carbone; K Mareschi; L Dughera; E C Farina; O Alabiso; G Valente; G Emanuelli; U Rodeck Journal: Clin Cancer Res Date: 2000-06 Impact factor: 12.531
Authors: N Mitsiades; V Poulaki; G Mastorakos; S T Tseleni-Balafouta; V Kotoula; D A Koutras; M Tsokos Journal: J Clin Endocrinol Metab Date: 1999-08 Impact factor: 5.958
Authors: Lu Cao; Prashanth Prithviraj; Ritu Shrestha; Revati Sharma; Matthew Anaka; Kim R Bridle; George Kannourakis; Darrell H G Crawford; Aparna Jayachandran Journal: J Clin Med Date: 2021-05-19 Impact factor: 4.241